Philips is expanding its collaboration with Amazon Web Services (AWS) to offer its HealthSuite diagnostics portfolio on the cloud.
The Netherlands-based medtech states that the collaboration aims to unify diagnostic workflows, improve access to critical insights, and drive improved outcomes across clinical specialities.
Having already transitioned more than 150 healthcare sites across North America and Latin America to Philips HealthSuite Imaging on AWS, Philips said the expanded AWS collaboration is now focused on accelerating the migration of health systems to the cloud in Europe, including customer cloud migrations on the continent.
With its portfolio situated on the cloud, the company said it will offer a unified view of patient data from diverse diagnostic sources, including radiology images, digital pathology slides, and other clinical records, to support care team collaboration and optimise workflows.
The move will also give clinicians remote access to diagnostic, reporting, and workflow orchestration tools intended to enhance diagnostic capabilities across healthcare imaging, from diagnosis to treatment and follow-up.
Philips’s diagnostics portfolio includes radiology, digital pathology, and cardiology.
Philips’ CEO Roy Jakobs commented: “Philips’ cloud-based healthcare informatics solutions allow us to drive better outcomes across clinical disciplines, including radiology, digital pathology, and cardiology. We’re working closely with clinicians to ensure workflows become more efficient and give back valuable time to healthcare providers.
“Collaborating with AWS helps us to innovate faster and deliver better care for more people.”
Expanding diagnostics on the cloud also means that Philips will be able to utilise AWS’s genAI-based imaging insights. The company plans to develop genAI models using Amazon Bedrock to create applications that reduce administrative burden and save time on tasks such as annotating radiology images.
One such genAI use case Philips is looking into is conversational reporting, wherein clinicians can use conversational language to convert findings into structured reports.
Edward Steiner, chief and medical director of The York/WellSpan Advanced Prostate Care Center in Pennsylvania, US, explained: "With Philips’ concept of ambient reporting using genAI, you simply could speak in a conversational tone and a structured report is generated within seconds. My estimate is a 15% to 20% increase in efficiency, and this is just the start.”
According to GlobalData analysis, the global specialised AI application market will reach a valuation of $477.6bn by 2030, with the global conversational platforms market forecast to be worth $340.8bn by the same year.
Other companies in the medtech space have been making moves to use genAI to drive efficiencies in various ways. GE Healthcare recently announced plans to launch CareIntellect in 2025, a genAI-based platform for breast and prostate cancer applications that can organise structured and unstructured data, including medical images, records, and notes.
At the recent 2024 Veeva MedTech Summit in Amsterdam, the Netherlands, Zeiss outlined its plans to build a proof-of-concept genAI-based platform in partnership with Boston Consulting Group to simplify content creation and personalisation.
